News

The European Society of Gene & Cell Therapy (ESGCT)

Chameleon Biosciences Presents Poster on AAV Gene Therapy Redosing Success at ESGCT

October 12, 2022

The European Society of Gene & Cell Therapy (ESGCT) Welcomes Chameleon’s Animal Study Results Poster at its 29th Annual Conference in Edinburgh, U.K.

> Read More
Genine Winslow, presenter

Chameleon Founder Speaks at 2nd annual Gene Therapy Next Generation Vector Summit

July 20, 2022

CEO and scientist, Genine Winslow, presents Immune Suppressive AAV Based Gene Therapy for Repeat Dosing at annual event dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors.

> Read More
Alan Belicha, PhD

Chameleon Biosciences welcomes Alan Belicha, Ph.D.

May 23, 2022

We are pleased to announce and welcome Alan Belicha to the Chameleon team as Vice President of Business Development. In this role, Alan will guide Chameleon’s corporate development and partnering strategy, and contribute to financing efforts. We are excited to have Alan’s experience from the University of Buffalo, Mount Sinai Innovation Partners, and TTO Consulting Strategic available to our team,…

> Read More
Gene Therapy for Rare Disorders Summit

Chameleon Founder Speaks at 5th annual Gene Therapy for Rare Disorders Conference

March 10, 2022

Immunology and gene therapy CEO and scientist, Genine Winslow, presents innovative vector modifications at industry summit. Learn more about the conference and see the press release.

> Read More

Press Releases

  • July 19, 2022
    EIN Presswire: Chameleon Founder Speaks at 2nd annual Gene Therapy Next Generation Vector Summit /
    CEO and scientist presents Immune Suppressive AAV Based Gene Therapy for Repeat Dosing
  • April 29, 2022
    EIN PresswireMENAFN
    Science News Today: CEO/CFO Interviews Chameleon Biosciences, Inc. Founder CEO, Genine Winslow on how they are Expanding AAV Gene Therapies with EVADER™
  • March 9, 2022
    AP News, Benzinga, Yahoo! Finance:
    Chameleon Biosciences Founder to Speak at Gene Therapy Next Generation Vector Summit 2022 in Boston
  • Jan 5, 2022
    AP News, Big News Network, Digital JournalYahoo! Finance
    Chameleon Biosciences Appoints Silicon Valley Scientist and Entrepreneur, Dr. Thomas Chalberg, to Board Position

Startseite Tiroler Tageszeitung Online Nachrichten Seitens Jetzt!

September 2, 2021

Mit Book of Ra hat Novoline einen der beliebtesten Spielautomaten weltweit vom Portfolio. Nahezu die meisten Novoline-Slots lassen gegenseitig im Casino gemeinsam kostenlos ohne Anmeldung spielen. Mit einen Klassikern wie Sizzling Hot oder Lucky Lady’s Charm zählt Novoline vorwiegend im rahmen (von) deutschen Spielern abgeschlossen den beliebtesten Providern. Das Spieleangebot welcher Online Casinos ist natürlich mit dem von seiten klassischen…

> Read More